Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152,309,909
-
Total 13F shares
-
158,868,263
-
Share change
-
+411,740
-
Total reported value
-
$8,836,867,619
-
Put/Call ratio
-
67%
-
Price per share
-
$55.63
-
Number of holders
-
563
-
Value change
-
+$43,726,586
-
Number of buys
-
302
-
Number of sells
-
252
Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q3 2025
As of 30 Sep 2025,
BIO-TECHNE Corp - COMMON STOCK (TECH) was held by
563 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
158,868,263 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., MORGAN STANLEY, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., PRICE T ROWE ASSOCIATES INC /MD/, NEUBERGER BERMAN GROUP LLC, and MAVERICK CAPITAL LTD.
This page lists
563
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.